DermOQ Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$8.35M
DermOQ General Information
Description
Manufacturer of oxygen-infusing skincare products intended to promote cell regeneration and reduce the appearance of aging. The company's products are scientifically proven benefits of oxygen for the skin including speeding repair and recovery, boosting the skin metabolism, reviving regeneration, increasing collagen, lessening fine lines and wrinkles, enabling customers to have skincare products that are effective than traditional products.
Contact Information
Website
www.elementeight.comCorporate Office
- 14930 Ventura Boulevard
- Suite 325
- Sherman Oaks, CA 91403
- United States
Corporate Office
- 14930 Ventura Boulevard
- Suite 325
- Sherman Oaks, CA 91403
- United States
DermOQ Timeline
DermOQ Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series A) | 08-Jan-2025 | $8.35M | Completed | Generating Revenue | ||
| 1. Later Stage VC | 14-Nov-2023 | Completed | Generating Revenue |
DermOQ Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
DermOQ Comparisons
Industry
Financing
Details
DermOQ Competitors (1)
One of DermOQ’s competitors is ASC Regenity, a Private Equity-Backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ASC Regenity | Private Equity-Backed | London, United Kingdom |
DermOQ Patents
DermOQ Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026183543-A1 | Continuous infusion of therapeutic gas for cosmetic use | Pending | 28-Feb-2025 | ||
| US-20230233420-A1 | Oxygen generating face masks | Inactive | 26-Feb-2018 | ||
| US-20240009087-A1 | Oxygen generating face masks | Inactive | 26-Feb-2018 | ||
| US-20250312247-A1 | Oxygen generating face masks | Pending | 26-Feb-2018 | ||
| EP-3664770-A1 | Therapeutic gas infused cosmetic and methods of infusion | Active | 08-Aug-2017 | B01F23/23121 |
DermOQ Signals
DermOQ Investments (2)
DermOQ’s most recent deal was a Later Stage VC with Blueground for . The deal was made on 28-Mar-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Blueground | 28-Mar-2024 | Later Stage VC | Real Estate Services (B2C) | ||
| Skin Products (ECHO2 Plus and Oxyceuticals) | 23-Dec-2020 | Corporate Asset Purchase | Buildings and Property |
DermOQ FAQs
-
When was DermOQ founded?
DermOQ was founded in 2017.
-
Where is DermOQ headquartered?
DermOQ is headquartered in Sherman Oaks, CA.
-
What is the size of DermOQ?
DermOQ has 5 total employees.
-
What industry is DermOQ in?
DermOQ’s primary industry is Personal Products.
-
Is DermOQ a private or public company?
DermOQ is a Private company.
-
What is DermOQ’s current revenue?
The current revenue for DermOQ is .
-
How much funding has DermOQ raised over time?
DermOQ has raised $14.4M.
-
Who are DermOQ’s competitors?
ASC Regenity is a competitor of DermOQ.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process